This paper shows anthropometric differences among four regions of urban community using Korean anthropometric data surveyed in 1992. The anthropometric data include 84 measurements of Korean aged 12~50. The principal component analysis reduce 84 measures to five components. The discriminant analysis using these components is performed to observe the anthropometric differences among four regions : Seoul and Kyungki, Kangwon and Chungbuk, Chungnam and Ch lla, Kyungsang. The results on age groups (12~14, 15~17, 18~24, 25~50 ages) and city size (big city, medium city, small city) can be summarized as follows ; 1) In male aged 12~14 and 15~17, there are significant differences of anthropometry among four regions in all city size. But in another age groups (18~24 and 25~50 ages), these are not significant differences of anthropometry among four regions except medium city. 2) In female, there are significant differences of anthropometry in all city sloe in aged 18~24 and 25~50 and in medium city in aged 15~17. however, there are not significant differences in aged 12~14 and 15-17.
Anthropometry ; Chungcheongbuk-do ; Chungcheongnam-do ; Discriminant Analysis ; Female ; Gangwon-do ; Humans ; Male ; Principal Component Analysis ; Seoul

No abstract available.
Lichen Planus ; Lichens

No abstract available.
Tattooing ; Warts

No abstract available.
Animals ; Horns* ; Keratoderma, Palmoplantar*

No abstract available.
Capillaries* ; Hemangioma, Capillary*

Pulmonary hypertension is an uncommon but serious complication of systemic lupus erythematosis (SLE).Usually its outcomes are ominous and may progress to heart failure and even sudden death.The pathophysiology is still unknown, but several mechanisms,such as pneumonitis,vasculitis,thromboembolism or thrombosis in situ have been proposed.There is no definitive therapy for this condition.Although supportive measures with vasodilators remain the mainstay of treatment,the responses are generally disappointing. We describe a case of improvement of pulmonary hypertension in SLE treated with cyclophosphamide pulse therapy as documented by hemodynamic data. Immunosuppressive treatment with cyclophosphamide was effective in this condition,suggested an immune mediated pathogenesis.
Cyclophosphamide* ; Heart Failure ; Hemodynamics ; Hypertension, Pulmonary* ; Lupus Erythematosus, Systemic* ; Thrombosis ; Vasodilator Agents

BACKGROUND: Ventricular septal defect (VSD) is rare but feared complication after acute myocardial infarction. The patient could survive by surgery only, but the surgical mortality is still high. We investigate the surgical result and predictors for early surgical mortality. MATERIAL AND METHOD: Between August 1993 and February 2006, 8 patients (male, 2; female, 6) with postinfarct VSD underwent surgical repair. Seven patients had one-vessel disease of left anterior descending artery, and 6 of them had wide extension of infarction to posterior septal wall as well as anterior septal wall of both ventricles. One patient had concomitant coronary bypass grafting to a coronary lesion unrelated to the infarction. Two patients had concomitant tricuspid annuloplasty and 1 patient mitral valvuloplasty. RESULT: Surgical mortality was 37.5% (3 patients). They all had only one-vessel disease of left anterior descending artery, which made extended posterior septal wall infarction as well as anterior septal wall infarction of both ventricles. In preoperative M-mode echocardiographic study of left ventricle, they had lower ejection fraction than survivors (34.9+/-4.2 vs. 54.8+/-12.3; p=0.036). CONCLUSION: Most of patients with postinfarction VSD had one-vessel disease of left anterior descending artery. Early surgical mortality occurred in the patients with poor ejection fraction of left ventricle and the wide anterior septal wall infarction extending to the posterior septum.
Arteries ; Echocardiography ; Female ; Heart Septal Defects, Ventricular* ; Heart Ventricles ; Humans ; Infarction ; Mortality ; Myocardial Infarction ; Survivors ; Transplants

No abstract available.
Female ; HELLP Syndrome* ; Pregnancy*

p21Cip/WAF1, an important regulator of cell proliferation, is induced by both p53- and extracellular signal regulated kinase (ERK) pathways. The induction of p21Cip/WAF1 occurs by prolonged activation of the ERKs caused by extracellular stimuli, such as zinc. However, not all the cells appeared to respond to ERK pathway dependent p21Cip/WAF1 induction. Here we investigated the cause of such difference using colorectal cancer cells. p21Cip/WAF1 induction and concomitant reduction of bromodeoxyuridine (BrdU) incorporation were observed by zinc treatment within HT-29 and DLD-1. However, HCT-116 cells with high endogenous p21Cip/WAF1 levels did not show any additional increment of p21Cip/WAF1 levels by zinc treatment and did maintain high BrdU incorporation level. The p21Cip/WAF1 induction by zinc depended upon prolonged activation of extracellular signal regulated kinase (ERK) was not observed in HCT-116 cells. The percentage of BrdU positive cells was 50% higher in p21Cip/WAF1 -/- HCT-116 cells compared to p21Cip/WAF1 +/+ HCT- 116 cells, and no cells induced p21Cip/WAF1 incorporated BrdU in its nucleus, yet confirming the importance of p21Cip/WAF1 induction in anti- proliferation. These results again support that p21Cip/WAF1 induction is a determinant in the regulation of colonic proliferation by the ERK pathway.
Bromodeoxyuridine/metabolism ; Cell Cycle Proteins/*metabolism ; Cell Line, Tumor ; Cell Proliferation ; Colorectal Neoplasms/enzymology/*metabolism ; Enzyme Activation ; Extracellular Signal-Regulated MAP Kinases/metabolism/*physiology ; Flavonoids/pharmacology ; Humans ; Protein Kinase Inhibitors/pharmacology ; Research Support, Non-U.S. Gov't ; Signal Transduction/drug effects ; Zinc/pharmacology

Quantitative measurement of BK virus DNA (Q-BKDNA) has been used for the early diagnosis and monitoring of BK virus-associated nephropathy (BKVAN). This study was designed to determine the BKDNA cutoff for the diagnosis of BKVAN. Between June 2005 and February 2007, 64 renal transplant recipients taken renal biopsies due to renal impairment submitted plasma and urine for Q-BKDNA. Eight BKVAN patients (12.5%) had median viral loads of 6.0 log(10) copies/mL in plasma and 7.3 log(10) copies/mL in urine. Among 56 non-BKVAN patients, 45 were negative for Q-BKDNA; 4 were positive in plasma with a median viral load of 4.8 log(10) copies/ mL, and 10 were positive in urine with a median viral load of 4.8 log(10) copies/mL. Receiver operating characteristic curve analysis showed that a cutoff of 4.5 log(10) copies/mL in plasma and a cutoff of 5.9 log(10) copies/mL in urine had a sensitivity of 100% and a specificity of 96.4%, respectively. A combined cutoffs of 4 log(10) copies/ mL in plasma and 6 log(10) copies/mL in urine had better performance with a sensitivity of 100% and a specificity of 98.2% than each cutoff of urine or plasma. QBKDNA with the combined cutoffs could reliably diagnose BKVAN in renal transplant recipients.
Adolescent ; Adult ; BK Virus/*genetics ; Biopsy ; Calibration ; DNA, Viral/*genetics ; Female ; Humans ; Kidney Diseases/*virology ; Kidney Transplantation/*methods ; Male ; Middle Aged ; Polymerase Chain Reaction ; Polyomavirus Infections/diagnosis ; Treatment Outcome